Sun Pharma on Wednesday denied insider trading charges against Silverstreet Developers LLP -- its wholly owned arm -- in the $4 billion acquisition deal of Ranbaxy Laboratories. Silverstreet......
In a setback to Sun Pharma-Ranbaxy merger process, Andhra Pradesh High Court has issued orders to Bombay Stock Exchange and National Stock Exchange to maintain interim status quo on the......